Your browser doesn't support javascript.
loading
Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals.
Jog, Neelakshi R; Young, Kendra A; Munroe, Melissa E; Harmon, Michael T; Guthridge, Joel M; Kelly, Jennifer A; Kamen, Diane L; Gilkeson, Gary S; Weisman, Michael H; Karp, David R; Gaffney, Patrick M; Harley, John B; Wallace, Daniel J; Norris, Jill M; James, Judith A.
Afiliação
  • Jog NR; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
  • Young KA; Department of Epidemiology, University of Colorado Anschutz Medical Campus, Colorado School of Public Health, Aurora, Colorado, USA.
  • Munroe ME; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
  • Harmon MT; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
  • Guthridge JM; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
  • Kelly JA; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
  • Kamen DL; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Gilkeson GS; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Weisman MH; Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Karp DR; Division of Rheumatic Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Gaffney PM; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
  • Harley JB; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Wallace DJ; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
  • Norris JM; US Department of Veterans Affairs Medical Center, Cincinnati, OH, United States.
  • James JA; Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Ann Rheum Dis ; 78(9): 1235-1241, 2019 09.
Article em En | MEDLINE | ID: mdl-31217170

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoimunidade / Herpesvirus Humano 4 / Infecções por Herpesviridae / Lúpus Eritematoso Sistêmico / Anticorpos Antivirais / Antígenos Virais Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoimunidade / Herpesvirus Humano 4 / Infecções por Herpesviridae / Lúpus Eritematoso Sistêmico / Anticorpos Antivirais / Antígenos Virais Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos